ENPH vs IBRX · P/E 56, rev $1.47B vs rev $51.2M
Enphase Energy Inc (ENPH) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
ENPH currently screens at market cap $7.39B and trailing P/E 55.5. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the ENPH and IBRX stock pages for the full models.
Not investment advice.